These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 21899726)
1. Sorting through the many opportunities for melanoma therapy. Herlyn M; Villanueva J Pigment Cell Melanoma Res; 2011 Oct; 24(5):975-7. PubMed ID: 21899726 [No Abstract] [Full Text] [Related]
3. Have we won the race in the treatment of advanced melanoma-or are we just learning to walk? Luke JJ Oncology (Williston Park); 2015 Feb; 29(2):136, 138-9. PubMed ID: 25683835 [No Abstract] [Full Text] [Related]
4. An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma. Asundi J; Reed C; Arca J; McCutcheon K; Ferrando R; Clark S; Luis E; Tien J; Firestein R; Polakis P Clin Cancer Res; 2011 Mar; 17(5):965-75. PubMed ID: 21245091 [TBL] [Abstract][Full Text] [Related]
6. Effect of a photoactivated rhodium complex in melanoma. Kim MR; Morrison H; Mohammed SI Anticancer Drugs; 2011 Oct; 22(9):896-904. PubMed ID: 21642837 [TBL] [Abstract][Full Text] [Related]
7. New therapeutic targets in melanoma. Martà RM; Sorolla A; Yeramian A Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672 [TBL] [Abstract][Full Text] [Related]
9. [To outwit melanoma with its own tricks]. Bischoff A MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255 [No Abstract] [Full Text] [Related]
10. Combination of targeted therapy and immunotherapy in melanoma. Blank CU; Hooijkaas AI; Haanen JB; Schumacher TN Cancer Immunol Immunother; 2011 Oct; 60(10):1359-71. PubMed ID: 21847631 [TBL] [Abstract][Full Text] [Related]
11. Molecular markers of response to treatment for melanoma. Sznol M Cancer J; 2011; 17(2):127-33. PubMed ID: 21427556 [TBL] [Abstract][Full Text] [Related]
12. Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond. Sullivan RJ; Atkins MB Expert Opin Investig Drugs; 2010 Oct; 19(10):1205-16. PubMed ID: 20687784 [TBL] [Abstract][Full Text] [Related]
13. Current and planned multicenter trials for patients with primary or metastatic melanoma. Sondak VK; Han D; Deneve J; Kudchadkar R J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839 [TBL] [Abstract][Full Text] [Related]
14. Melanoma and immunotherapy. Eggermont AM; Schadendorf D Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602 [TBL] [Abstract][Full Text] [Related]
15. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models. Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412 [TBL] [Abstract][Full Text] [Related]